Novavax (NVAX) closed at $8.19 in the latest trading session, marking a +0.74% move from the prior day. This move outpaced the S&P 500's daily gain of 0.67%. At the same time, the Dow added 0.38%, and ...

Amid sixth outbreak of Sudan Ebola virus, Ugandans bemoan lack of official communication and fears for the economy.

24, 2025 — A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical ...

Uganda's sixth outbreak of the Sudan type of the virus. The Sudan vaccine is a similarly designed vaccine to Ervebo.

There are no approved vaccines or treatments for Sudan virus disease, which has a 40–70% fatality rate. To curb the ongoing outbreak, Uganda has deployed—under a clinical trial setting—a vaccine ...

Amid a new Ebola outbreak in Kampala, Uganda, the World Health Organization has kicked off a vaccine trial. This is the first ...

WHO and the Uganda Health Ministry have launched a first-ever vaccine trial for the species of Ebola at the center of an ongoing outbreak in Uganda’s capital city.

The World Health Organization's emergencies director on Friday praised the "fastest roll-out" of an Ebola vaccine trial in ...

Ugandan authorities have begun a clinical trial of a vaccine against the Sudan strain of Ebola that has killed one person in ...

The vaccine candidate is being evaluated in a ring vaccination trial as part of a comprehensive public health response ...

Ugandan officials are preparing to deploy a trial vaccine as part of efforts to stem an outbreak of Ebola in the capital, ...

It is planned to use up to 2,000 vaccine doses, despite the fact that this is an experimental vaccine, which has not yet been licensed ...